CClinicalTrials.gg
CompletedNCT02219464Updated Jun 1, 2017Results posted

Nasopharyngeal Versus Nasal Cannula Oxygen Supplementation in Surgery Patients

An interventional study of Nasopharyngeal catheter and Nasal Cannula in Oxygen Administration During Deep Sedation, sponsored by Vanderbilt University. Completed at 1 site in United States. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2017-06-01.

Sponsored by Vanderbilt University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

The investigators plan to conduct a randomized, controlled trial comparing nasopharyngeal oxygen supplementation to traditional nasal cannula in patients undergoing oral surgery under moderate sedation.

02

Conditions studied

  • Oxygen Administration During Deep Sedation

Keywords

  • nasopharyngeal catheter
  • nasal cannula
03

In context

Lead sponsor

Vanderbilt University is the lead sponsor of 508 studies on the registry; 19 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 5 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients greater than 16 years of age
  • Patients who present for oral surgery or esophagoduodenography and colonoscopy
  • Patients who undergo intravenous sedation

Exclusion criteria

Exclusion Criteria:

  • Patients who require endotracheal intubation
  • ASA class 4 or higher
  • Existing esophageal disease such as a perforation or varices
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Nasopharyngeal catheter

    Patients in this arm will receive oxygen supplementation through the use of a Nasopharyngeal catheter. Sedation will be standardized to ensure consistency between groups.

    Device: Nasopharyngeal catheter · Procedure: Oxygen Supplementation · Procedure: Sedation

  • Other
    Nasal Cannula

    Patients will receive oxygen supplementation through the use of a traditional nasal cannula. Sedation will be standardized to ensure consistency between groups.

    Device: Nasal Cannula · Procedure: Oxygen Supplementation · Procedure: Sedation

Interventions

  • DeviceNasopharyngeal catheter
  • DeviceNasal Cannula
  • ProcedureOxygen Supplementation

    Initially set at 3 liters/minute

  • ProcedureSedation

    Midazolam 2mg IV, Fentanyl 100mcg IV, Propofol 100 mcg/kg/min. Additional doses of propofol at the discretion of the attending anesthesiologist.

06

What researchers measure

Primary outcomes

  1. Number of Participants With Oxygen Saturations Below 92%

    Time frame: During surgical procedure

Secondary outcomes

  1. Number of Participants Who Needed Airway Assistance Interventions

    (jaw lift, tongue retraction, oral airway placement, mask ventilation, increase in oxygen flow rate, ect.).

    Time frame: During surgical procedure

07

Results

Posted Jun 1, 2017

Participant flow

Participant flow — Overall Study
MilestoneNasopharyngeal CatheterNasal Cannula
Started3030
Completed2730
Not completed30
Withdrew: Withdrawal by subject10
Withdrew: Case cancelled10
Withdrew: Catheter malfunction10

Outcome measures

PrimaryNumber of Participants With Oxygen Saturations Below 92%
Time frame:
During surgical procedure
Reported as:
Count of participants · Participants
Number of Participants With Oxygen Saturations Below 92%
ParticipantsNasopharyngeal CatheterNasal Cannula
Number of Participants With Oxygen Saturations Below 92%312
SecondaryNumber of Participants Who Needed Airway Assistance Interventions

(jaw lift, tongue retraction, oral airway placement, mask ventilation, increase in oxygen flow rate, ect.).

Time frame:
During surgical procedure
Reported as:
Count of participants · Participants
Number of Participants Who Needed Airway Assistance Interventions
ParticipantsNasopharyngeal CatheterNasal Cannula
Number of Participants Who Needed Airway Assistance Interventions417

Adverse events

Collected over Adverse events were monitoring for the entire procedure all the way through the patients discharge from the post-anesthesia care unit. This would average around 4 hours of time; however, no time limit was placed on our adverse event monitoring. Once the procedure started to the point they were taken to their form of transportation, each subject was monitored for an adverse event.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Nasopharyngeal Catheter0/27 (0%)0/27 (0%)1/26 (3.8%)
Nasal Cannula0/30 (0%)0/30 (0%)0/30 (0%)
Most frequent other events
Most frequent other events
EventNasopharyngeal CatheterNasal Cannula
Nose BleedInjury, poisoning and procedural complications1/260/30

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Nasopharyngeal CatheterNasal CannulaTotal
<=18 years000
Between 18 and 65 years192039
>=65 years81018
Sex: Female, Male
Sex: Female, Male(Participants)Nasopharyngeal CatheterNasal CannulaTotal
Female121426
Male151631
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Nasopharyngeal CatheterNasal CannulaTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)Nasopharyngeal CatheterNasal CannulaTotal
United States273057
08

Study locations

1 site
  • Vanderbilt University Medical Center
    Nashville, Tennessee 37232, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 1, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02219464
Lead sponsor
Vanderbilt University
Responsible party
Bret Alvis (Assistant Professor, Vanderbilt University) — Principal investigator
First posted
Aug 19, 2014
Start date
Aug 2014
Primary completion
Dec 2015
Completion
Jan 2016
Results posted
Jun 1, 2017
Last update
Jun 1, 2017

Study contacts

Bret Alvis, MD
principal investigator · Vanderbilt University Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion